Order Article Reprints

Hallermayr A, Steinke-Lange V, Vogelsang H, Rentsch M, de Wit M, Haberl C, Holinski-Feder E, Pickl JMA. Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management. Cancers. 2022; 14(3):851. https://doi.org/10.3390/cancers14030851

Hallermayr, Ariane, Verena Steinke-Lange, Holger Vogelsang, Markus Rentsch, Maike de Wit, Christopher Haberl, Elke Holinski-Feder, and Julia M. A. Pickl. 2022. "Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management" Cancers 14, no. 3: 851. https://doi.org/10.3390/cancers14030851

Hallermayr, A., Steinke-Lange, V., Vogelsang, H., Rentsch, M., de Wit, M., Haberl, C., Holinski-Feder, E., & Pickl, J. M. A. (2022). Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management. Cancers, 14(3), 851. https://doi.org/10.3390/cancers14030851